Article

Prospective Assessment of a Quantitative Immunofluorescent Assay to Measure HER2 and TROP2 concentrations on a Single Tissue Biopsy Slide

2025-11-11

Abstract excerpt

<title>Abstract</title> <p>With over 700 antibody-drug conjugates (ADCs) in clinical trials and multiple approvals for the same indications, new challenges arise in protein-based diagnostics. In general, higher levels of ADCs target specific proteins are associated with increased response to the drug. We believe a new biomarker category (selective biomarkers) is needed to help the physician decide which ADC best...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 28fe9572-0186-51bb-a82f-b9503697a6c6
DOI: 10.21203/rs.3.rs-7785005/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prospective Assessment of a Quantitative Immunofluorescent Assay to Measure HER2 and TROP2 concentrations on a Single Tissue Biopsy SlideDOI 10.21203/rs.3.rs-7785005/v1Read

Validation and Prospective Testing of a High Sensitivity, Quantitative Analytic Assay for HER2 on Histopathology SlidesSemantic proximity Read

Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel ApproachSemantic proximity Read

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].Semantic proximity Read

Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancer.Semantic proximity Read

Germline Genetic Modulation of Systemic TROP2 Abundance: A Human Genetics–Guided Framework for Stratification of TROP2-Directed Antibody–Drug ConjugatesSemantic proximity Read

Quantitative Protein Expression of Antibody–Drug Conjugate Targets in EGFR Mutated and Wild-type Non–Small Cell Lung CancerSemantic proximity Read

Breast cancer biomarker measurements and standardsSemantic proximity Read

Genomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumors.Semantic proximity Read

Quantitation of HER2 and telomerase biomarkers in solid tumors with IgY antibodies and nanocrystal detectionSemantic proximity Read

ADC Target Profiling in NSCLC: Generalizable AI Separates TROP-2 and cMET Phenotypes.Semantic proximity Read

Continuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancerSemantic proximity Read

<i>In vivo</i> Auto-tuning of Antibody-Drug Conjugate Delivery for Effective Immunotherapy using High-Avidity, Low-Affinity AntibodiesSemantic proximity Read